Pharmos Receives Notice Related to Nasdaq Minimum Bid Price Rule
September 28, 2007 16:01 ET
|
Pharmos Corporation
ISELIN, N.J., Sept. 28, 2007 (PRIME NEWSWIRE) -- Pharmos Corporation (Nasdaq:PARS) today announced that it received notice on September 26, 2007 from The Nasdaq Stock Market that the minimum bid price...
Pharmos Commences Phase 2b Irritable Bowel Syndrome Study
June 20, 2007 08:30 ET
|
Pharmos Corporation
ISELIN, N.J., June 20, 2007 (PRIME NEWSWIRE) -- Pharmos Corporation (Nasdaq:PARS) announced today patient screening has commenced in its Phase 2b clinical trial of dextofisopam, which is expected to...